SEC Form 4 · accession 0001267959-26-000003
CalciMedica, Inc. · CALC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fred A Middleton
Director · 10% Owner
Period of report
Jun 25, 2026
Accepted (ET)
Jun 29, 2026 · 8:45 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001534133
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jun 25, 2026 | P | 248,972 | $0.8033 | A | 1,063,272 | I | By Sanderling Venture Partners VI Co-Investment Fund, L.P. |
| Common StockF3 | holding | — | — | — | 946,744 | I | By Sanderling Venture Partners VI, LP | |
| Common StockF3 | holding | — | — | — | 22,479 | I | By Sanderling Ventures Management VI | |
| Common StockF3 | holding | — | — | — | 7,456 | I | By Sanderling VI Beteligungs GmbH & Co KG | |
| Common StockF3 | holding | — | — | — | 8,884 | I | By Sanderling VI Limited Partnership | |
| Common StockF4 | holding | — | — | — | 435,148 | I | By Sanderling Ventures VII, L.P. | |
| Common StockF5 | holding | — | — | — | 114,260 | I | By Sanderling Ventures VII (Canada), L.P. | |
| Common StockF5 | holding | — | — | — | 27,609 | I | By Sanderling Ventures VII Annex Fund, L.P. | |
| Common StockF5 | holding | — | — | — | 30,292 | I | By Sanderling Ventures Management VII | |
| Common StockF6 | holding | — | — | — | 8,176 | I | By Golden Triangle Ventures, LLC | |
| Common Stock | holding | — | — | — | 36,514 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated June 23, 2026, with a closing date of June 25, 2026. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors.
- F2The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the securities of the Issuer held by Sanderling Venture Partners VI Co-Investment Fund, LP ("SVP VI Co-Investment, LP", together with Sanderling Venture Partners VI, LP., Sanderling VI Beteiligungs GmbH & Co. KG, Sanderling Ventures Management VI and Sanderling VI Limited Partnership (the "Sanderling VI Securities"). The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
- F3The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the Sanderling VI Securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- F4The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the securities of the Issuer held by Sanderling Ventures VII, LP ("SVP VII, LP", together with Sanderling Ventures Management VII, Sanderling Ventures VII (Canada), L.P. and Sanderling Ventures VII Annex Fund, L.P., the "Sanderling VII Securities"). The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- F5The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the Sanderling VII Securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- F6The Reporting Person is a managing member of Golden Triangle Ventures LLC and may be deemed to beneficially own the securities of the Issuer held by Golden Triangle Ventures LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.